Assessment of the safety of pembrolizumab in patients with HIV and advanced cancer—a phase 1 study
TS Uldrick, PH Gonçalves, M Abdul-Hay… - JAMA …, 2019 - jamanetwork.com
Importance Anti− PD-1 (anti− programmed cell death 1) and anti− PD-L1 (anti− programmed
cell death ligand 1) regimens are preferred therapies for many cancers, including cancers …
cell death ligand 1) regimens are preferred therapies for many cancers, including cancers …
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study
TS Uldrick, PH Gonçalves, M Abdul-Hay… - JAMA …, 2019 - pubmed.ncbi.nlm.nih.gov
Importance Anti-PD-1 (anti-programmed cell death 1) and anti-PD-L1 (anti-programmed cell
death ligand 1) regimens are preferred therapies for many cancers, including cancers …
death ligand 1) regimens are preferred therapies for many cancers, including cancers …
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.
TS Uldrick, PH Gonçalves, M Abdul-Hay… - JAMA …, 2019 - europepmc.org
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A
Phase 1 Study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
Phase 1 Study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
[HTML][HTML] Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
TS Uldrick, PH Gonçalves, M Abdul-Hay… - JAMA …, 2019 - ncbi.nlm.nih.gov
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A
Phase 1 Study - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
Phase 1 Study - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI …
[PDF][PDF] Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
TS Uldrick, PH Gonçalves, M Abdul-Hay, AJ Claeys… - 2019 - natap.org
OBJECTIVE The primary objective was to evaluate the safety of pembrolizumab in people
with HIV and advanced cancer; the secondary objective was to evaluate tumor responses …
with HIV and advanced cancer; the secondary objective was to evaluate tumor responses …
[引用][C] Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
TS Uldrick, PH Gonçalves, M Abdul-Hay, AJ Claeys… - JAMA Oncology, 2019 - cir.nii.ac.jp
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A
Phase 1 Study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Phase 1 Study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF][PDF] Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study
TS Uldrick, PH Gonçalves, M Abdul-Hay, AJ Claeys… - 2019 - natap.org
OBJECTIVE The primary objective was to evaluate the safety of pembrolizumab in people
with HIV and advanced cancer; the secondary objective was to evaluate tumor responses …
with HIV and advanced cancer; the secondary objective was to evaluate tumor responses …
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.
TS Uldrick, PH Gonçalves, M Abdul-Hay… - JAMA …, 2019 - europepmc.org
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A
Phase 1 Study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …
Phase 1 Study. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …